Caricamenti by Nagalase

The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy

Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor

Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF

Retraction Note to

Retracted

T.101. Treatment of HIV-Infected Patients with Gc Protein-Derived Macrophage Activating Factor (GcMAF) and Its Coned Derivative (GcMAFc) Eradicates HIV-Infection

Retraction Note to

Retracted

GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients

Pathogenic Significance of α-N-Acetylgalactosaminidase Activity Found in the Envelope Glycoprotein gp160 of Human Immunodeficiency Virus Type 1

Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al

Retraction Note to

RETRACTED ARTICLE

Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus

Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation

Serum α-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix